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Translational genomics is changing, not only in the
technology used but also in the sharing of data.
The enormous potential for genomics technologies to
improve patient care has been recognized, but it
will not be reached unless powerful but secure
data-sharing technologies are developed. A recent
study demonstrates the power of federated queries, in
which sequence variants can be searched simultaneously
in files distributed over multiple centers.2009, about a decade after the introduction of genome-Changing practices in translational genomics
The past few years have witnessed several shifts in the
practice of exome and genome sequencing. Thanks to the
dramatic drop in cost and to the increasing penetration of
bioinformatics into clinical medicine and translational re-
search, numerous groups around the world have adopted
these technologies and used them to identify hundreds of
novel Mendelian disease genes, and next-generation se-
quencing (NGS) is making its way into routine clinical
diagnostics. Hand in hand with these technological ad-
vances, new challenges are emerging for bioinformatics in
translational genomics. Read mapping and variant calling
are by no means simple, routine procedures, as recent re-
ports on the low concordance of different variant calling
pipelines [1] suggest. However, there are mature, if imper-
fect, algorithms available for these tasks, and widely used
tools, such as the GATK best practices pipeline [2], provide
high-quality variant calls. On the other hand, the field
of translational bioinformatics is now confronted with
numerous unsolved problems in data interpretation andCorrespondence: peter.robinson@charite.de
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support algorithms that use NGS data to help solve clinical
problems.
Data sharing for translational genomics
The enormous potential for genomics technologies to
improve patient care has been recognized in fields as
diverse as rare diseases, cancer, immunology, infectious
diseases, prediction of medication side effects, and ther-
apy stratification for patients with common diseases.
Progress in these fields will depend on data sharing. In
wide association studies (GWASs), the term 'missing
heritability' was introduced to describe the fact that only
a small proportion of variance in a population attribut-
able to additive genetic factors had been discovered by
GWASs [3]. More recently, however, a series of common
diseases have started to yield their secrets to GWASs
with larger study sizes than those of earlier GWASs, in-
cluding some with tens of thousands of patients and over
100,000 controls [4]. Theoretical considerations suggest
that rare variant association studies using genome sequen-
cing will require similar study sizes to achieve statistical
power [5]. Such large numbers can rarely be achieved by a
single study, so sharing of genomic data will be required
to make progress in the understanding of the genetic basis
of common disease, and new technologies for enab-
ling and streamlining genomic data sharing while main-
taining privacy of study participants could benefit the field
greatly.
There are substantial barriers to data sharing at the
scale that is needed to enable progress in genomic medi-
cine. These include: technical issues surrounding storing
terabytes, petabytes, and soon exabytes of data, and trans-
porting at least part of the data across public and private
networks; ethical and privacy issues to protect the rights
of sequenced individuals; and statistical and algorithmic
issues about the best ways of combining disparate
datasets to address biomedical research questions. We. The licensee has exclusive rights to distribute this article, in any medium, for
me, the article is available under the terms of the Creative Commons Attribution
y/4.0), which permits unrestricted use, distribution, and reproduction in any
credited. The Creative Commons Public Domain Dedication waiver (http://
applies to the data made available in this article, unless otherwise stated.
Robinson Genome Medicine 2014, 6:78 Page 2 of 3
http://genomemedicine.com/content/6/9/78cannot provide a comprehensive review of genomic
data-sharing initiatives here, but even in the field of
rare diseases, a wide variety of approaches can be dis-
cerned. For example, ClinVar intends to provide a catalog
of genetic variants together with their clinical conse-
quences, with over 120,000 variants at the time of writing
[6]. DECIPHER (DatabasE of genomiC varIants and
Phenotype in Humans Using Ensembl Resources) is an
international community of academic departments of clin-
ical genetics and rare disease genomics that together have
deposited genomic variants and phenome data from more
than 14,450 cases for which consent has been given for
public display [7]. DECIPHER has facilitated over 600
publications since its inception in 2004. Since 2014,
DECIPHER has integrated data sharing for sequence
variants, indels and copy number variants and has a
zoomable browser that enables display across the genomic
scale, from nucleotide to chromosome. DECIPHER is fully
searchable by phenotype, gene name, and genomic pos-
ition. In 2014, an intermediate layer of data sharing was
implemented, enabling DECIPHER centers to share data
with nominated partners; this enables more restricted
sharing, which can facilitate interpretation when consent
for full data sharing has not been given. Finally, Phenome-
Central is a repository for secure data sharing targeted at
clinicians and scientists working on rare disorders [8]. The
website uses phenotypic clustering based on phenotypic
similarity using data encoded with the Human Phenotype
Ontology, which has become a widely used resource for
exchanging and analyzing data in medical genetics [9].
This can be used to identify multiple individuals affected
by the same disorder, allowing data from multiple centers
to be integrated in the same search in an effective and
secure manner.
Several ambitious new genomic initiatives are forming
with the goal of enabling data sharing by fostering agree-
ment about data standards and technical interfaces. Sev-
eral such initiatives have been shown to be particularly
valuable. These include the Human Genome Variation
Society (HGVS), with its widely accepted guidelines for
mutation nomenclature, and the Human Variome Project
(HVP), which spearheads the collection, curation, inter-
pretation, and sharing of information on variation in
the human genome. Newer projects have also shown
promise, including the International Rare Disease Research
Consortium (IRDiRC), initially founded by the National
Institutes of Health and the European Commission, which
aims to promote diagnostics for all rare diseases and
accelerate the development of new treatments for them; it
promotes standards for data and samples and also for
other areas, including ethical and regulatory procedures.
IRDiRC members are funding bodies and other organi-
zations that will promote the use of these standards by
funded researchers. Another newer project is the GlobalAlliance for Genomics and Health (GAGH), which pro-
motes similar goals for all areas of genomic medicine,
including rare disease. One of the projects that is emer-
ging from the GAGH is the Beacon Project, a technical
interface for implementing a web service that allows lim-
ited sharing of genetic data. A genomic variant query can
be conducted at a participating 'beacon' and will answer
the question of whether the institution has one or more
human genomes with a certain allele at a certain position
(the answer is a simple 'yes' or 'no'). Thus, if a research
group has identified an interesting rare variant at a certain
position of the genome, it can easily find out whether
other centers have additional genomes with the variant in
question. At the time of writing, seven such beacons were
listed at the GAGH website.
The logistics of sharing genomic data
Current paradigms of sharing raw genomic data (such as
FASTQ or BAM files) will not scale well for certain re-
search goals, especially those that require a large amount
of data to be integrated. For instance, the European
Genome-phenome Archive (EGA) of the European Bio-
informatics Institute (EBI) and the database of Genotypes
and Phenotypes (dbGaP) of the National Center for Bio-
technology Information (NCBI) are large archives for vari-
ous types of genomic data. However, data access decisions
are made for individual datasets, and thus it would not be
easy for a user to obtain access and download 10 sets of
100 genomes each from 10 unrelated centers to perform
an integrated computational analysis on all of the data.
In this issue of Genome Medicine, Ardeshirdavani and
coworkers describe software, NGS-Logistics [10], which
provides solutions to several data-sharing challenges that
have not yet been sufficiently addressed by other groups.
As an illustration of the potential utility of NGS-Logistics,
imagine an international research consortium with 10
groups, each of which performs genome sequencing on
100 patients with a certain disease under study. Imagine
that one of the ten groups identifies a mutation in a really
promising candidate gene called RPCG1, but the statistical
evidence provided by the analysis of the first group is not
sufficient for publication. There are currently several op-
tions available to our imaginary consortium for making
progress. It could decide to put all 1,000 genomes into a
central repository, but this would require additional IT
resources, and also the willingness of all 10 groups to
share their data before publication. Alternatively, the first
group could ask each of the other nine groups to share
data on the RPCG1 gene in each of the 100 genomes. But
even if nine postdocs in the nine groups found the time to
search out and copy the data, it still might be difficult for
the first group to complete the analysis because of dif-
ferent formats or variant-calling settings being used in the
other nine groups.
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http://genomemedicine.com/content/6/9/78NGS-Logistics provides a different solution for this, in
which each of the 10 centers installs the NGS-Logistics
software and lets the software know where to find the
100 BAM files. This now allows each of the centers to
ask a hypothesis-driven question about a gene or a variant.
In the example above, the first center could use NGS-
Logistics to run variant calling using its own preferred
GATK parameters in the RPCG1 gene at all 100 BAM files
of all 10 centers. The variant calling is performed locally
at each of the centers, and the results are collected and
returned to the first center, a procedure that is known as a
federated search. If the researcher at the first center thinks
the results are of potential interest, NGS-Logistics can be
used to request more data access. Importantly, the re-
searcher at the first center is not allowed to download the
genomes from the other centers, thus preserving privacy
and respecting the intellectual property of collaborating
groups. NGS-Logistics instead allows researchers to ask
hypothesis-driven questions about specific variants or
specific genes, such as RPCG1 above, which can lead to
targeted follow-up studies within collaborative networks.
NGS-Logistics therefore may be useful to research con-
sortia that are acquiring too much data to move from one
partner to another and that for one of many reasons
choose not to store their data in a central archive.
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